Patents for C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132) |
---|
08/28/2012 | US8252924 Process for preparing benzomorpholine derivatives by hydrogenating o-nitrophenoxy carbonyl compounds |
08/28/2012 | US8252923 Peptidomimetic protease inhibitors |
08/28/2012 | US8252788 Therapeutic compounds |
08/28/2012 | US8252209 Photochromic compounds based on ring opening and closing of an [1,3]oxazine compound |
08/28/2012 | CA2535412C Process for the preparation of n-arylmorpholinones |
08/23/2012 | WO2012110833A2 Fluorescence modulators |
08/23/2012 | WO2012090177A3 Cannabinoid receptor modulators |
08/23/2012 | WO2011154827A3 Transition metal-catalyzed processes for the preparation of n-allyl compounds and use thereof |
08/23/2012 | US20120214953 Phosphorus-containing compounds useful for making halogen-free, ignition-resistant polymers |
08/23/2012 | US20120214806 3-amino-5-phenyl-5,6-dihydro-2h-[1,4]oxazines |
08/23/2012 | US20120214800 Organic Compounds |
08/23/2012 | US20120214782 New compounds, pharmaceutical compositions and uses thereof |
08/21/2012 | US8247401 P2X3 receptor antagonists for treatment of pain |
08/16/2012 | US20120208804 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure |
08/16/2012 | US20120208797 Pyrimidone derivatives |
08/16/2012 | US20120207765 Chemokine receptor antagonists and use thereof |
08/15/2012 | CN102639516A 3-amino-5-phenyl-5,6-dihydro-2h-[1,4]oxazine derivatives |
08/14/2012 | US8242268 Production of bepromoline |
08/14/2012 | US8242267 Polymorphs of efavirenz |
08/14/2012 | CA2544649C Morpholine derivatives as norepinephrine reuptake inhibitors |
08/14/2012 | CA2531088C Photochromic compounds |
08/09/2012 | WO2012104865A1 N, n- dialkyl -morpholin- 4 - carboxamide compounds as insect repelling agents and a process for their preparation |
08/09/2012 | US20120202995 Process for the preparation of 2-(2-aminoethoxy) ethanol (2aee) and morpholine with 2aee: morpholine >3 |
08/09/2012 | US20120202993 Method of preparing cyclic carbonates, cyclic carbamates, cyclic ureas, cyclic thiocarbonates, cyclic thiocarbamates, and cyclic dithiocarbonates |
08/09/2012 | CA2817841A1 1,4 oxazines as bace1 and/or bace2 inhibitors |
08/08/2012 | EP2483255A1 Oxazine derivatives and their use in the treatment of neurological disorders |
08/08/2012 | EP1838296B1 Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases |
08/02/2012 | WO2012101245A1 Polymerizable composition comprising an oxime sulfonate as thermal curing agent |
08/02/2012 | US20120196863 1,4 oxazines as bace1 and/or bace2 inhibitors |
08/02/2012 | US20120196813 Glycoside derivative and uses thereof |
08/01/2012 | EP2481732A1 Condensed ring compound and use thereof |
08/01/2012 | CN102617580A Vasopressin V1a Antagonists |
08/01/2012 | CN102617567A Lactam-containing compounds and derivatives thereof as factor Xa inhibitors |
08/01/2012 | CN102617503A Novel synthetic method of (S)-3-morpholinyl carboxylic acid |
07/31/2012 | US8231690 Composition comprising derivatives of phenoxazinones for hair colouring |
07/26/2012 | WO2012098064A1 1,4 oxazines as bace1 and/or bace2 inhibitors |
07/26/2012 | WO2012097511A1 Dmp-266 by cyclisation |
07/26/2012 | WO2012097510A1 Process for preparation of efavirenz by cyclisation |
07/26/2012 | US20120190816 Asymmetric synthesis of peptides |
07/26/2012 | US20120190675 Azaspirohexanones |
07/26/2012 | US20120189492 Fullerene compositions and methods for photochemical purification |
07/26/2012 | CA2819158A1 1,4 oxazines as bace1 and/or bace2 inhibitors |
07/25/2012 | CN102603695A Amino acid-fluorophore compound and application thereof |
07/25/2012 | CN102603665A Synthesis method of 4-(4-aminophenyl)-3-morpholone |
07/25/2012 | CN101921266B 3,4,6-triaryl-[1,3]-oxazine compound as well as preparation method and application thereof |
07/19/2012 | WO2012095803A1 New fluorescent compounds |
07/19/2012 | US20120184540 1,4 oxazines as bace1 and/or bace2 inhibitors |
07/19/2012 | US20120184438 Formulations |
07/18/2012 | CN102596921A Novel compounds |
07/18/2012 | CN102584801A One pot method asymmetric synthesis process of HIV reverse transcriptase inhibitor Efavirenz compound |
07/18/2012 | CN102584738A New technology for synthesizing rivaroxaban intermediate |
07/18/2012 | CN102584736A Method for catalyzing and oxidizing hydroxamic acids |
07/18/2012 | CN102584604A Low-VOC polyamino alcohols |
07/18/2012 | CN101952262B Halogen-free benzoxazine based curable compositions for high TG applications |
07/17/2012 | US8222408 Process for preparing acyl amide compounds |
07/17/2012 | US8222405 Phenylalanine derivatives |
07/17/2012 | US8222247 Modulators of glucocorticoid receptor, AP-1, and/or NF-kappabeta activity and use thereof |
07/12/2012 | WO2012094622A2 Amination of aryl alcohol derivatives |
07/12/2012 | WO2012092873A1 Synthetic rivaroxaban intermediate and preparation method thereof |
07/12/2012 | US20120178925 Polymers bearing pendant pentafluorophenyl ester groups, and methods of synthesis and functionalization thereof |
07/12/2012 | US20120178915 Pyrimidine derivatives and analogs, preparation method and use thereof |
07/12/2012 | US20120178747 Compositions and methods for bone formation and remodeling |
07/11/2012 | EP2474531A2 Matrix metalloproteinase inhibitors |
07/11/2012 | EP2473492A1 Process for the preparation of (1s,4r)-2-oxa-3-azabicyclo[2,2.1]hept-5-enes |
07/11/2012 | EP2473491A1 Morpholinone compounds as factor ixa inhibitors |
07/11/2012 | EP2473490A1 (thio)morpholine derivatives as s1p modulators |
07/11/2012 | CN102574843A Fused ring analogues of anti-fibrotic agents |
07/11/2012 | CN102574778A Novel biphenyl and phenyl-pyridine amides |
07/11/2012 | CN101646662B Novel prophylactic and/or therapeutic agent for diabetic neuropathy |
07/10/2012 | US8217063 Lactam-substituted dicarboxylic acids and use thereof |
07/10/2012 | CA2469191C [1,2]-oxazine-3,5-diones |
07/05/2012 | WO2012090177A2 Cannabinoid receptor modulators |
07/05/2012 | WO2012064744A3 N- sulfonylated tetrahydroquinolines and related bicyclic compounds inhibition of rory activity and the treatment of diseases |
07/05/2012 | US20120172357 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
07/04/2012 | EP2471783A1 Novel polymorphic form of efavirenz |
07/04/2012 | CN1845911B Condensed ring compound and use thereof |
07/04/2012 | CN102548976A (Thio) morpholine derivatives as S1P modulators |
07/04/2012 | CN102532062A Benzoyl urea compound and synthesis method thereof |
07/04/2012 | CN102531813A Process for continuous hydrogenation or hydrogenating amination |
07/04/2012 | CN101898982B Npy y5 antagonists |
07/04/2012 | CN101296912B Theramutein modulators |
07/03/2012 | US8212049 Electronically tuned ligands for asymmetric hydrogenation |
07/03/2012 | CA2568356C Bicyclic heterocycles as hiv integrase inhibitors |
06/28/2012 | WO2012088314A1 Bicyclic pkm2 activators |
06/28/2012 | WO2012087720A1 Methods of making diastereomeric organic compounds |
06/28/2012 | US20120165521 Low-voc polyamino alcohols |
06/28/2012 | US20120165276 Quaternary alkyl ammonium bacterial efflux pump inhibitors and therapeutic uses thereof |
06/28/2012 | DE112010001630T5 Monomer, Polymerisationsverfahren und Polymer Monomer, polymerization and polymer |
06/28/2012 | CA2822432A1 Bicyclic pkm2 activators |
06/27/2012 | EP2467368A1 3-amino-5-phenyl-5,6-dihydro-2h-[1,4]oxazine derivatives |
06/27/2012 | EP1389611B1 20-hydroxyeicosatetraenoic acid production inhibitors |
06/27/2012 | CN102516204A Substituted morpholine and thiomorpholine derivatives |
06/27/2012 | CN102516194A Benzoxazine intermediate and its preparation method |
06/27/2012 | CA2759346A1 Low-voc polyamino alcohols |
06/26/2012 | US8207227 Disodium salts, monohydrates, and ethanol solvates for delivering active agents |
06/26/2012 | US8207167 Aryl-phenyl-sulfonamide-phenylene compounds and their use |
06/26/2012 | US8207164 Oxazine derivatives and their use in the treatment of neurological disorders |
06/26/2012 | US8207163 Compositions, synthesis, and methods of using piperazine based antipsychotic agents |
06/26/2012 | CA2635093C Derivatives of sulindac, use thereof and preparation thereof |
06/26/2012 | CA2575232C 5-substituted-2-phenylamino-benzamide as mek inhibitor |